Primary Site >> Stomach Cancer

Gene >> TFAP2E

Journal: Cancer Lett. 2015 Jul 10;363(1):7-16.
Title: Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2'-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics.
Author: Wu, Feng-lei|Li, Ru-Tian|Yang, Mi|Yue, Guo-Feng|Wang, Hui-yu|Liu, Qin|Cui, Fang-bo|Wu, Pu-yuan|Ding, Hui|Yu, Li-Xia|Qian, Xiao-Ping|Liu, Bao-Rui
PMID: 25592042
Journal: Technol Cancer Res Treat. 2016 Apr;15(2):285-95.
Title: Transcription Factor AP2epsilon: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.
Author: Sun, Jingyue|Du, Nan|Li, Jin|Zhou, Jianwei|Tao, Guoquan|Sun, Suan|He, Jingdong
PMID: 25810491
Journal: Oncotarget. 2017 Sep 26;8(70):114495-114505.
Title: Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon.
Author: Hong, Yi-Dong|Zhang, Jian|Zhuang, Ming|Li, Wei|Wu, Puy-Uan|Li, Ru-Tian|Hu, Nan|Bian, Bao-Xiang|Song, Zi-Yan|Wu, Feng-Lei
PMID: 29383097